← Leaderboards
Nora Singer
Case Western Reserve University
$3,497,199
Attributed
$5,255,896
Total exposure
7
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $436.2K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,255,896 · 7
By mechanism
R01$3,537,220 · 2
R21$992,419 · 2
R34$464,801 · 1
R43$223,198 · 1
P60$38,258 · 1
Top collaborators
- Salvatore Albani6 shared
- Hillard M Lazarus4 shared
- Sara Stern2 shared
- Ludovic Trinquart2 shared
- Sivaram P Gogineni1 shared
Most similar at Case Western Reserve University
Same institution · by research overlap
- Sahera Dirajlal-Fargo$3,377,246
- Raymond F Muzic$5,871,932
- Nicholas T. Funderburg$7,518,795
- Claudio Fiocchi$14,319,606
- Scott Michael Welford$5,685,124
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectClinical TrialsCellsCytokineFutureEarly TreatmentPathway InteractionsMeasurementEffective TherapyTherapy Clinical TrialsRheumatologyResponseAutoimmunityImmune ToleranceImmuneImmune SystemMethotrexateDesignImmunoregulationArthritisSeriesChildhoodResearch PersonnelRegimen
Grant awards (20)
Planning a childhood sJOgren disease Use of Randomized N-of-1 Evaluation of therapY JOURNEY$166,861
R34 · FY2025 · AR · contact PI
Planning a childhood sJOgren disease Use of Randomized N-of-1 Evaluation of therapY JOURNEY$297,940
R34 · FY2024 · AR · contact PI
Cell-based Therapy in RA: Proof of Concept$215,308
R21 · FY2018 · AR · contact PI
Cell-based Therapy in RA: Proof of Concept$41,055
R21 · FY2018 · AR · contact PI
Cell-based Therapy in RA: Proof of Concept$213,995
R21 · FY2017 · AR · contact PI
Clinical Evaluation of Point of Care Raman Analysis for Diagnosis of Gout$223,198
R43 · FY2016 · AR
Cell-based Therapy in RA: Proof of Concept$182,311
R21 · FY2016 · AR · contact PI
Mechanisms of Immune Modulation in JIA$380,698
R01 · FY2013 · AR
Mechanisms of Immune Modulation in JIA$400,735
R01 · FY2012 · AR
Mechanisms of Immune Modulation in JIA$393,893
R01 · FY2011 · AR
Mechanisms of Immune Modulation in JIA$410,305
R01 · FY2010 · AR
Mechanisms of Immune Modulation in JIA$432,238
R01 · FY2009 · AR
Mechanisms of Immune Modulation in JIA$3,923
R01 · FY2009 · AR
CD6: Thymic Selection and Immune Response$325,933
R01 · FY2006 · AI · contact PI
CD6: Thymic Selection and Immune Response$334,006
R01 · FY2005 · AI
CD6: Thymic Selection and Immune Response$339,114
R01 · FY2004 · AI
CD6: Thymic Selection and Immune Response$344,250
R01 · FY2003 · AI
CD6: Thymic Selection and Immune Response$172,125
R01 · FY2002 · AI
CD6: Thymic Selection and Autoimmunity$339,750
R21 · FY2001 · AI
CD6 T LYMPHOCYTE COSTIMULATORY MOLECULE--IMMUNE DEVELOPMENT &AUTOIMMUNE DISEASE$38,258
P60 · FY2000 · AR